The Nerve Growth Factor IB-like Receptor Nurr1 (NR4A2) Recruits CoREST 2 Transcription Repressor Complexes to Silence HIV Following Proviral Reactivation 3 in Microglial Cells

[1]  Ashutosh Kumar Singh,et al.  Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress , 2020, bioRxiv.

[2]  J. D. del Río,et al.  Macrophagic and microglial complexity after neuronal injury , 2020, Progress in Neurobiology.

[3]  Ella Borgenheimer,et al.  Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator , 2020, International journal of molecular sciences.

[4]  J. Middeldorp,et al.  Profiling Microglia From Alzheimer’s Disease Donors and Non-demented Elderly in Acute Human Postmortem Cortical Tissue , 2020, Frontiers in Molecular Neuroscience.

[5]  K. Kuter,et al.  Overview of General and Discriminating Markers of Differential Microglia Phenotypes , 2020, Frontiers in Cellular Neuroscience.

[6]  P. Edison.  Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases. , 2020, International review of neurobiology.

[7]  M. Nonnemacher,et al.  Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND , 2020, Cellular and Molecular Life Sciences.

[8]  L. Brunsveld,et al.  Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation , 2020, Nature Reviews Endocrinology.

[9]  Jian-Young Wu,et al.  Increased matrix metalloproteinase levels and perineuronal net proteolysis in the HIV-infected brain; relevance to altered neuronal population dynamics , 2020, Experimental Neurology.

[10]  B. Brew,et al.  The impact of HIV central nervous system persistence on pathogenesis. , 2019, AIDS.

[11]  J. Karn,et al.  Cross-talk between microglia and neurons regulates HIV latency , 2019, PLoS pathogens.

[12]  C. Van Lint,et al.  Microglial Cells: The Main HIV-1 Reservoir in the Brain , 2019, Front. Cell. Infect. Microbiol..

[13]  S. Safe,et al.  Structure‐dependent activation of gene expression by bis‐indole and quinoline‐derived activators of nuclear receptor 4A2 , 2019, Chemical biology & drug design.

[14]  David Torrents,et al.  Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes , 2019, Nature Genetics.

[15]  Li-gong Bian,et al.  Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia , 2018, CNS neuroscience & therapeutics.

[16]  J. Karn,et al.  Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir , 2018, Proceedings of the National Academy of Sciences.

[17]  J. Karn,et al.  The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells , 2018, Journal of Neuroimmune Pharmacology.

[18]  J. Bamburg,et al.  HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity , 2018, Current HIV research.

[19]  G. Landreth,et al.  Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease , 2018, Journal of Neuroinflammation.

[20]  J. Karn,et al.  HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency , 2017, Journal of NeuroVirology.

[21]  E. Eugenin,et al.  HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim , 2017, Scientific Reports.

[22]  J. Karn,et al.  Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells , 2017, Retrovirology.

[23]  Wei Liu,et al.  Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models. , 2017, Biochemical and biophysical research communications.

[24]  J. Karn,et al.  Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system , 2016, Journal of NeuroVirology.

[25]  J. Karn,et al.  Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis , 2016, Scientific Reports.

[26]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[27]  Jingying Zhu,et al.  Target of HIV-1 Envelope Glycoprotein gp120-Induced Hippocampal Neuron Damage: Role of Voltage-Gated K(+) Channel Kv2.1. , 2015, Viral immunology.

[28]  Alexander Dobin,et al.  Mapping RNA‐seq Reads with STAR , 2015, Current protocols in bioinformatics.

[29]  G. Petsko,et al.  Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease , 2015, Proceedings of the National Academy of Sciences.

[30]  O. Isacson,et al.  A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C) , 2015, PloS one.

[31]  J. Alonso,et al.  NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells , 2015, Thrombosis and Haemostasis.

[32]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[33]  B. Brew,et al.  Update on HIV Dementia and HIV-Associated Neurocognitive Disorders , 2014, Current Neurology and Neuroscience Reports.

[34]  D. Michaelson,et al.  Reversal of apoE4-Driven Brain Pathology and Behavioral Deficits by Bexarotene , 2014, The Journal of Neuroscience.

[35]  C. Van Lint,et al.  HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters , 2014, Nucleic acids research.

[36]  Sonia Shah,et al.  Epigenetics, Drugs of Abuse, and the Retroviral Promoter , 2013, Journal of Neuroimmune Pharmacology.

[37]  A. Björklund,et al.  NURR1 in Parkinson disease—from pathogenesis to therapeutic potential , 2013, Nature Reviews Neurology.

[38]  Alessandro Marcello,et al.  HIV-1 transcription and latency: an update , 2013, Retrovirology.

[39]  E. Masliah,et al.  Molecular and pathologic insights from latent HIV-1 infection in the human brain , 2013, Neurology.

[40]  V. Rivera-Amill,et al.  Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory , 2013, Neurobiology of Disease.

[41]  H. Deng,et al.  Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson’s disease , 2012, European journal of neurology.

[42]  J. Karn,et al.  Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells , 2012, Journal of NeuroVirology.

[43]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[44]  C. Van Lint,et al.  LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing , 2011, Nucleic acids research.

[45]  Marketa Zvelebil,et al.  High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing , 2011, Genome Biology.

[46]  J. Eells,et al.  NR4A Gene Expression Is Dynamically Regulated in the Ventral Tegmental Area Dopamine Neurons and Is Related to Expression of Dopamine Neurotransmission Genes , 2011, Journal of Molecular Neuroscience.

[47]  J. Karn,et al.  Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2 , 2011, Journal of Virology.

[48]  D. Kolson,et al.  Current understanding of HIV-associated neurocognitive disorders pathogenesis. , 2011, Current opinion in neurology.

[49]  A. Basu,et al.  Microglial response to viral challenges: every silver lining comes with a cloud. , 2011, Frontiers in bioscience.

[50]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[51]  T. Harkins,et al.  Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing , 2010, Proceedings of the National Academy of Sciences.

[52]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[53]  P. Tontonoz,et al.  A Nurr1 Pathway for Neuroprotection , 2009, Cell.

[54]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[55]  J. Mey,et al.  RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases , 2008, Progress in Neurobiology.

[56]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[57]  F. Dequiedt,et al.  Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing , 2007, The EMBO journal.

[58]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[59]  Bernard Roizman,et al.  Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Van Lint,et al.  COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells , 2005, Nucleic acids research.

[61]  Kwang-Soo Kim,et al.  ß Federation of European Neuroscience Societies Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation , 2022 .

[62]  D. Dormont,et al.  [Neurotoxicity and neuroprotection, two aspects of microglial activation in human immunodeficiency virus (HIV) infection]. , 2004, Annales de pathologie.

[63]  E. Arenas,et al.  Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. , 2003, Genes & development.

[64]  K. S. A. Wansa,et al.  The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine* , 2003, Journal of Biological Chemistry.

[65]  P. Ordentlich,et al.  Identification of the Antineoplastic Agent 6-Mercaptopurine as an Activator of the Orphan Nuclear Hormone Receptor Nurr1* , 2003, Journal of Biological Chemistry.

[66]  C. Van Lint,et al.  Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system. , 2002, Biochemical pharmacology.

[67]  O. Prospero-Garcia,et al.  [HIV glycoprotein 120: possible etiological agent of AIDS-associated dementia]. , 2002, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[68]  M. Smidt,et al.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Miklossy,et al.  HIV-I Induced Destruction of Neocortical Extracellular Matrix Components in AIDS Victims , 1997, Neurobiology of Disease.

[70]  D. Aunis,et al.  COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells* , 1997, The Journal of Biological Chemistry.

[71]  B. A. Cohen.  Neurologic complications of HIV infection. , 1997, Primary care.

[72]  L. Olson,et al.  Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. , 1996, Molecular endocrinology.

[73]  C. Van Lint,et al.  Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation. , 1996, The EMBO journal.

[74]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[75]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[76]  C. Achim,et al.  Immunopathogenesis of HIV Encephalitis , 1991, Brain pathology.

[77]  L. Resnick,et al.  Early penetration of the blood‐brain‐barrier by HIV , 1988, Neurology.

[78]  D. Ferrari,et al.  Activation of microglial cells by beta-amyloid protein and interferon-gamma. , 1995, Nature.

[79]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.